An interesting study showed that knocking down NRF2 in pregnancy-associated hypertension (PAH) mice (NRF2−/− PAH mice), a mouse model of PE, improved maternal and fetal survival, ameliorated intra-uterine growth retardation and increased oxidative DNA damage. Here, NFE2L2 is linked to pulmonary arterial hypertension.